DOCK4: Dedicator of Cytokinesis 4

A guanine nucleotide exchange factor (GEF) for Rac1 and Rho GTPases involved in cell migration, adhesion, and neuronal development.

Gene Information Card

Symbol DOCK4
Full Name Dedicator of cytokinesis 4
Gene Type Protein coding
Chromosomal Location 7q31.1
NCBI Gene ID 9732 ncbi.nlm.nih.gov/gene/9732
Ensembl ID ENSG00000128512
UniProt ID Q8N1I0
OMIM ID 607679
HGNC ID 19192
Aliases KIAA0716, MGC138207, MGC138209

Description

DOCK4 (Dedicator of cytokinesis 4) encodes a member of the DOCK family of guanine nucleotide exchange factors (GEFs) that activate small GTPases of the Rho family, particularly Rac1. The protein contains a DOCK homology region 2 (DHR2) domain responsible for GEF activity and a DHR1 domain that binds phospholipids. DOCK4 is involved in cell migration, adhesion, neurite outgrowth, and phagocytosis. Mutations and altered expression of DOCK4 have been implicated in autism spectrum disorders, schizophrenia, and various cancers, including ovarian and colorectal cancer.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Autism spectrum disorder Missense and frameshift mutations in DOCK4 disrupt Rac1 activation, impairing neuronal connectivity and synaptic function. PMID: 16936731; ClinVar
Schizophrenia Rare copy number variants and SNPs in DOCK4 are associated with increased risk, possibly through altered dendritic spine morphology. PMID: 21926972; OMIM
Ovarian cancer DOCK4 overexpression promotes cell migration and invasion via Rac1 signaling; loss of heterozygosity at 7q31.1 is frequent. PMID: 22952450; COSMIC
Colorectal cancer DOCK4 mutations (e.g., R1197X) lead to loss of GEF activity and reduced cell adhesion, contributing to metastasis. PMID: 19252532; COSMIC

Expression Profile

Tissue Expression
Tissue nTPM level
Brain 12.3 Medium
Lung 8.7 Low
Ovary 15.2 Medium
Colon 9.1 Low
Testis 18.5 High
Cell Line Expression
Cell Line nTPM Notes
HEK293 14.6 Embryonic kidney; moderate expression
HeLa 11.2 Cervical carcinoma; moderate expression
SH-SY5Y 22.1 Neuroblastoma; high expression
OVCAR-3 19.8 Ovarian cancer; high expression
HCT116 8.4 Colorectal carcinoma; low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
R1197X Nonsense <1% Loss of GEF activity; truncated protein; associated with colorectal cancer
E1118K Missense <0.5% Impaired Rac1 binding; linked to autism
c.2074delC Frameshift <0.1% Premature stop; loss of function; autism spectrum disorder
Gln1138His Missense <0.3% Reduced Rac1 activation; reported in schizophrenia
Mutation functional classification

Loss of Function (LOF)

Nonsense and frameshift mutations (e.g., R1197X, c.2074delC) result in truncated or unstable protein, reducing Rac1-GEF activity and impairing cell migration and adhesion.

Gain of Function (GOF)

Not well documented; overexpression in ovarian cancer may act as a gain-of-function by enhancing Rac1 signaling and promoting invasion.

Dominant Negative (DN)

Missense mutations (e.g., E1118K) may produce a dominant-negative effect by sequestering Rac1 or disrupting DOCK4 dimerization, leading to reduced downstream signaling.

Pathways

• Rac1 signaling pathway (Reactome: R-HSA-9012999)
• Rho GTPase cycle (Reactome: R-HSA-194840)
• Signaling by Rho family GTPases (Reactome: R-HSA-194315)
• Cell migration and adhesion (KEGG: hsa04510)

Protein Summary

DOCK4 is a 1,982-amino-acid protein (UniProt Q8N1I0) that functions as a guanine nucleotide exchange factor (GEF) specifically for Rac1, but not for Cdc42 or RhoA. It contains an N-terminal DHR1 domain that binds phosphatidylinositol (3,4,5)-trisphosphate (PIP3), targeting the protein to the plasma membrane, and a C-terminal DHR2 domain that catalyzes nucleotide exchange on Rac1. DOCK4 also interacts with ELMO proteins to enhance GEF activity. The protein is critical for cytoskeletal remodeling during cell migration, neurite outgrowth, and phagocytosis. Alternative splicing produces multiple isoforms, and post-translational modifications include phosphorylation and ubiquitination.

Related Products

Product name Cat.No. Species Gene ID
DOCK4 Knockout HEK293 Cell Line EDJ-KQ1285 Human 9732 Details Get a Quote
DOCK4 Knockout A-549 Cell Line EDJ-KQ19338 Human 9732 Details Get a Quote
DOCK4 Knockout HCT 116 Cell Line EDJ-KQ20685 Human 9732 Details Get a Quote
DOCK4 Knockout HeLa Cell Line EDJ-KQ20686 Human 9732 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: